期刊文献+

SIRT1表达与结肠癌细胞多药耐药性的关系 被引量:3

下载PDF
导出
摘要 目的建立结肠癌耐药细胞系,初步研究SIRT1表达与结肠癌细胞多耐药性的关系。方法建立耐药细胞系HCT-8/VCR。MTT法测其交叉耐药性。RT-PCR法和免疫细胞化学法分别检测SIRT1基因的mRNA水平和蛋白水平的表达,初步探讨其与肿瘤细胞多药耐药的关系。结果建立对长春新碱高度耐药的结肠癌细胞系,RT-PCR法和免疫细胞化学法表明SIRT1在HCT-8/VCR的表达增强。结论 SIRT1基因的表达与HCT-8/VCR的耐药性有一定的关系,耐药细胞SIRT1的表达明显比亲本细胞中的高。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2012年第2期339-340,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献6

  • 1李咏,李电东,何琪杨.组蛋白去乙酰化酶抑制剂调节肿瘤细胞多药耐药性的机制[J].中国新药杂志,2008,17(15):1295-1297. 被引量:9
  • 2Sinha M,Peterson CL.Chromatin dynamics during repair of chromosomalDNA double-strand breaks[J].Epigenomics,2009;1(2):371-85.
  • 3Phipps SM,Love WK,White T,et al.Retinoid-induced histone deacetyla-tion inhibits telomerase activity in estrogen receptor-negative breast canc-er cells[J].Anticancer Res,2009;29(12):4959-64.
  • 4Parsons BL,Meng F.K-RAS mutation in the screening,prognosis andtreatment of cancer[J].Biomark Med,2009;3(6):757-69.
  • 5Masuda K,Marasa B,Martindale JL,et al.Tissue-and age-dependent ex-pression of RNA-binding proteins that influence mRNA turnover andtranslation.
  • 6Diande S,Sangare L,Kouanda S,et al.Drug resistance of mycobacteriumtuberculosis complex among newly diagnosed tuberculosis cases in burki-na[J].Faso West afr J Med,2009;28(6):353-7.

二级参考文献20

  • 1GOTTESMAN MM, FOJO T, BATES SE. Multidrug resistance in cancer: role of ATP-dependent transporters [ J ]. Nat Rev Cancer, 2002,2( 1 ) : 48 - 58.
  • 2KRUTH GD, BELINSKY MG. The MRP family of drug efflux pumps[J]. Oncogene, 2003, 22(47):7537-7552.
  • 3BAKER EK, EL-OSTA A. The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer [ J ]. Exp Cell Res, 2003, 290(2) : 177 - 194.
  • 4KOUZARIDES T. Chromatin modifications and their function [J]. Cell, 2007, 128(3): 693 -705.
  • 5BORDONE L, GUARENTE L. Calorie restriction, SIRT1 and metabolism: understanding longevity [ J ]. Nat Rev Mol Cell Biol, 2005, 6(4): 298 -305.
  • 6MARCHION D, MUNSTER P. Development of histone deacetylase inhibitors for cancer treatment [ J ]. Expert Rev Anticancer Ther, 2007, 7(4) : 583 -598.
  • 7LEGGAS M, PANETTA JC, ZHUANG Y, et al. Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo[J]. CancerRes, 2006, 66(9): 4802 -4807.
  • 8RUEFLI AA, AUSSERLECHNER MJ, BERNHARD D, et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species[J], Proc Natl Acad Sci, 2001, 98(19): 10833 - 10838.
  • 9RUEFLI AA, BERNHARD D, TAINTON KM, et al. Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells[J]. Int J Cancer, 2002, 99(2) :292 -298.
  • 10TANG R, FAUSSAT AM, MAJDAK P, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRPI [ J ]. Leukemia, 2004, 18 (7) :1246 - 1251.

共引文献8

同被引文献56

  • 1刘玲,何玲,刘国卿.P糖蛋白与细胞凋亡及肿瘤多药耐药的关系[J].药学进展,2005,29(3):101-105. 被引量:15
  • 2Canavan TP, DOSHI NR. Cervical cancer[J]. American Family Physi- cian, 2000, 61(5): 1369-1382.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA: A Cancer Journal for Clinicians, 2011, 61(2): 69-90.
  • 4Monk B J, Willmott LJ, Sumner DA. Anti-angiogenesis agents in meta- static or recurrent cervical cancer [J]. Gynecologic Oncology, 2010, 116(2): 181-186.
  • 5Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters[J]. Nature Reviews Cancer, 2002, 2(1): 48-58.
  • 6Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinic- al practice[J]. The Oncologist, 2003, 8(5): 411-424.
  • 7Fojo T, Bates S. Strategies for reversing drug resistance[J]. Oncogene, 2003, 22(47): 7512-7523.
  • 8Jones P, George A. The ABC transporter structure and mechanism: perspectives on recent research[J]. Cellular and Molecular Life Scienc- es, 2004, ~i1(6): 682-699.
  • 9Smoter M, Bodnar L, Duchnowska R, et al. The role of Tan protein in resistance to paclitaxel [J]. Cancer Chemotherapy and Pharmacology, 2011, 68(3): 553-557.
  • 10Gruber BM, Anuszewska EL, Bubko I, et al. Relationship between topoisomerase Ⅱ-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells[J]. Antic- ancer Research, 2005, 25(3B): 2193-2198.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部